RGNX today
$8.03-$0.44 (-5.19%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minLeaning Bullish
Daily trend turns down below $5.95
Key levels
Resistance$9.18
Resistance$8.16
Support$7.58
Support$6.46
Latest news & SEC filings
EarningsREGENXBIO wraps patient sign-up for key sura-vec studies, posts Q3 2026 results
AnalystMizuho Sets $18 Target for REGENXBIO
EarningsRegenxbio holds Q3 2026 earnings call
EarningsREGENXBIO Posts Q3 2026 Results
All RGNX news →About REGENXBIO
REGENXBIO is a biotech firm in the gene therapy field. It develops treatments that employ viral vectors from its proprietary NAV platform to carry working genes into cells. Its own programs focus on eye conditions, muscle disorders and nerve diseases, such as a vision-loss disease tied to aging, diabetic eye damage, a childhood muscle-wasting illness and inherited metabolic conditions. It also out-licenses its vectors to partners, whose products include an approved therapy for a motor neuron disease. The company is headquartered in Rockville, Maryland, where it runs its own production site.
Based on the company's 10-K filed Mar 5, 2026.
Nasdaq · Healthcare
REGENXBIO Inc. (RGNX)
What Is the Price Target for RGNX?
SEPT Low Target
$12.00
SEPT Mid Target
$19.50
SEPT High Target
$29.00
Analyst Consensus
$19.50
Is RGNX a Buy or Sell Right Now?
Thesis
- •Revenue growing 104.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RGNX.
Start Free Trial →Is RGNX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$15.51
15
Moat Score
NONE
3/9
Piotroski Score
-3.2
Altman Z-Score
What Is Smart Money Doing with RGNX?
Insider Signal
NEUTRAL
2 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Malzahn Craig | officer | Buy | 27,777 | - | Nov 1, 2026 |
| Chan Mitchell | officer | Buy | 24,305 | - | Nov 1, 2026 |
| PAKOLA STEVE | officer | Buy | 34,722 | - | Nov 1, 2026 |
| Christmas Patrick J. | officer | Buy | 34,722 | - | Nov 1, 2026 |
| Ciongoli Gregory Austin | director | Buy | 53,407 | $500K | Aug 27, 2026 |
| Ciongoli Gregory Austin | director | Buy | 49,196 | $450K | Aug 26, 2026 |
| Ciongoli Gregory Austin | director | Buy | 15,432 | - | Aug 25, 2026 |
| Bennett Jean | director | Buy | 9,807 | - | May 29, 2026 |
| Zachary Jennifer | director | Buy | 9,807 | - | May 29, 2026 |
| Glucksmann Alexandra | director | Buy | 9,807 | - | May 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RGNX Growth Story
Revenue YoY
104.5%
3yr Revenue CAGR
14.8%
EPS Growth YoY
18.08%
FCF Growth YoY
28.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for RGNX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RGNX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:27:07 | $8.03 | 19,770 | $$159K | SELL |
| 21:00:32 | $8.03 | 4,800 | $$39K | SELL |
| 21:00:31 | $8.03 | 2,035 | $$16K | SELL |
| 21:00:03 | $8.03 | 1,198 | $$10K | SELL |
| 21:00:03 | $8.03 | 1,096 | $$9K | SELL |
5 dark pool trades shown · $$232K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for RGNX
PREVIEWSEPT Investing provides real-time options flow tracking for RGNX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $10 | Jan 15 | 64 | $$155 | 1 | SWEEP |
| CALL | $8 | Apr 16 | 155 | $$2475 | 9 | SWEEP |
2 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for REGENXBIO Inc. (RGNX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RGNX — frequently asked questions
What is RGNX stock price today?
REGENXBIO Inc. (RGNX) is at $8.03, down 5.19% (-$0.44) at the Nov 12, 2026 close.
Why is RGNX stock moving today?
Latest RGNX news — Nov 9, 2026: REGENXBIO wraps patient sign-up for key sura-vec studies, posts Q3 2026 results · Nov 6, 2026: Mizuho Sets $18 Target for REGENXBIO
Why did RGNX stock move on Nov 5, 2026?
Regenxbio reported its third-quarter 2026 results, posting a smaller-than-expected quarterly loss but revenue of $9.162 million that fell short of the $10.868 million projection. The company also filed a Form 8-K disclosing a major company event alongside its earnings call.
What is the RGNX price target?
The average analyst price target for RGNX is $19.50, ranging from $12 to $29, based on 6 analysts. Latest: Mizuho initiates on Oct 5, 2026.
What do analysts rate RGNX?
Analyst ratings for RGNX: 1 Buy, 8 Hold, 1 Sell — consensus Hold.
Did RGNX beat earnings?
RGNX last reported on Aug 6, 2026: EPS $0.43 vs $0.08 expected — a beat of 446.4%.
Does RGNX pay a dividend?
RGNX does not currently pay a dividend.
What are RGNX support and resistance levels?
Support: $7.58, $6.46, $5.46. Resistance: $8.16, $9.18, $10.10.
What are insiders doing with RGNX?
Insider activity: NEUTRAL, 2 buys and 2 sells in the last 90 days.
What is the latest news on RGNX?
Nov 9, 2026: REGENXBIO wraps patient sign-up for key sura-vec studies, posts Q3 2026 results · Nov 6, 2026: Mizuho Sets $18 Target for REGENXBIO · Nov 5, 2026: Regenxbio holds Q3 2026 earnings call